Filing Details

Accession Number:
0000899243-22-033177
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-06 21:15:12
Reporting Period:
2022-10-04
Accepted Time:
2022-10-06 21:15:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819133 Tango Therapeutics Inc. TNGX () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015747 Joseph Lewis Cay House, Ep Taylor Drive N7776,
Lyford Cay
New Providence C5
No No Yes No
1465836 Boxer Asset Management Inc. Cay House, Ep Taylor Drive N7776, Lyford
New Providence C5
No No Yes No
1465837 Boxer Capital, Llc 12860 El Camino Real, Suite 300
San Diego CA 92130
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-04 25,606 $3.67 6,897,248 No 4 P Direct
Common Stock Acquisiton 2022-10-05 45,500 $3.93 6,942,748 No 4 P Direct
Common Stock Acquisiton 2022-10-05 40,500 $3.84 6,983,248 No 4 P Direct
Common Stock Acquisiton 2022-10-06 70,394 $4.06 7,053,642 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors, LLC, and (vi) Aaron I. Davis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.